Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03022331 · ClinicalTrials.gov registry record
VCRC Longitudinal Protocol for Aortitis
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 16
- Enrollment target
NCT03022331: Completed study, sponsored by University of Pennsylvania.
NCT03022331 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03022331 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The term 'aortitis' refers to inflammation of the aorta. Aortitis is known to occur in a variety of vasculitides and connective tissue diseases, such as giant cell arteritis (GCA), Takayasu arteritis (TAK), rheumatoid arthritis, and spondyloarthropathies, among others. This study will establish a longitudinal cohort for these diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-12-04 |
| Est. Completion | 2019-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03022331
The ClinicalTrials.gov registry entry for NCT03022331 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03022331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03022331 about?
NCT03022331 is a clinical study titled "VCRC Longitudinal Protocol for Aortitis". The term 'aortitis' refers to inflammation of the aorta. Aortitis is known to occur in a variety of vasculitides and connective tissue diseases, such as giant cell arteritis (GCA), Takayasu arteritis (TAK), rheumatoid arthritis, and spondyloarthropathies, among others. This study will establish a lo...
What is the current status of trial NCT03022331?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2017-12-04. Estimated completion is 2019-09-01.
Who is sponsoring clinical trial NCT03022331?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.